NCT03457272

Brief Summary

Despite systems for early detection of critical illness, 12% of patients in the emergency department develop clinical deterioration with an increased risk of death as a result. There is a need for a intervention to support the identification and clinical management of patients at risk of clinical deterioration earlier hospitalization. The Cincinnati Children's Hospital has introduced a model that systematically complements systems for early detection of critical illness with the assessment of patient and relatives concern, clinical intuition and concern of the staff. In addition, the model includes formalized organizational processes aimed at systematic review of risk patients and early treatment efforts. Studies from United States indicate that the model can lead to reduction of serious incidental events and increase the staff awareness of the situation. The Cincinnati model is designed for children and has not yet been studied in a controlled study. Purpose To develop and investigate the impact of a Danish patient safety model. Method A literature review is conducted to identify risk factors that should be included in a model aimed at detecting and managing clinical deterioration. A patient safety model is developed on the basis of the literature review and the Cincinnati model and is tested in a pilot study. In a controlled intervention study, the effect is investigated against severe clinical deterioration. The intervention is carried out at the emergency departments at Horsens Regional Hospital and Viborg Regional Hospital with the regional hospitals in Randers and Herning as control departments.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34,556

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 30, 2017

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 4, 2017

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 7, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2018

Completed
Last Updated

October 14, 2019

Status Verified

October 1, 2019

Enrollment Period

7 months

First QC Date

December 4, 2017

Last Update Submit

October 11, 2019

Conditions

Keywords

Patient SafetyRisk FactorsQuality Indicators, Health CareRisk Assessment

Outcome Measures

Primary Outcomes (1)

  • The proportion of patients with severe clinical deterioration in the ED

    Severe clinical deterioration will be measured by the early warning system used in Central Denmark Region based on vital signs collected from medical records. The score is aggregated and the vital signs include respiratory rate, SatO2, systolic blood pressure, pulse, temperature and level of consciousness measured by APVU. The initial deterioration process from score 0-1 will be considered as "no deterioration". Deterioration directly to score 2 and above, or deterioration from score ≥2 and further will be considered severe.

    Participants will be followed for the length of stay in the Emergency Department, an expected period of 48 hours

Secondary Outcomes (10)

  • Safety awareness

    up to 4 weeks (in baseline and in intervention)

  • Proportion of participants with severe safety events

    Participants will be followed for the duration of the hospital stay in the Emergency Department, an expected average of 17 hours

  • Proportion of participants admitted to the Intensive Care Units from the Emergency Departments

    Participants will be followed for the duration of the hospital stay in the Emergency Department, an expected average of 17 hours

  • Proportion of participants admitted to the Intensive Care Units from the wards

    Participants will be followed for the duration of hospital stay, an expected average of 1 week

  • Length of stay at the Intensive Care Unit

    Participants will be followed for the duration of hospital stay, an expected average of 1 week

  • +5 more secondary outcomes

Study Arms (2)

New risk assessment

EXPERIMENTAL

New risk assesment

Other: New risk assessment

Standard

NO INTERVENTION

Standard risk assessment

Interventions

Consists of a simple physiological scoring system and an assessment of patients who should assist healthcare professionals in identifying patients at risk of clinical deterioration earlier and support timely response and escalation of observation, care and treatment and thereby prevent the development of severe clinical deterioration. The patients included in the study will be monitored using the new risk assessment tool with different intervals according to the patients' conditions. Underlying the tool are algorithms of action for intervention in the critically ill patient, inter professional guidelines and guidance for standardized monitoring, escalation plans and huddles.

New risk assessment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult somatic patients (≥18 years) admitted to the participating Emergency Departments

You may not qualify if:

  • Patients with injuries caused by trauma
  • Patients received with cardiac arrest, as a surgical or medical call (can participate if admitted to the Emergency Department and not directly transferred to the Intensive Care Unit)
  • Patients hospitalized with a psychiatric diagnosis as the primary cause of admission

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Herning Regional Hospital

Herning, 7400, Denmark

Location

Horsens Regional Hospital

Horsens, 8700, Denmark

Location

Randers Regional Hospital

Randers, 8930, Denmark

Location

Viborg Regional Hospital

Viborg, 8800, Denmark

Location

Study Officials

  • Gitte B Tygesen, PhD student

    Regionshospitalet Horsens

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The study consists of two intervention and two control departments. The intervention consists of a risk assesment to ensure systematic and standardized identification of patients in risk of clinical deterioration and a decision support algorithm. Actions are undertaken on the basis of the standardized decision support and when a patient is determined to be at risk escalation plans are activated. As part of the intervention, huddles are conducted and patients at risk are interdisciplinarily discussed.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 4, 2017

First Posted

March 7, 2018

Study Start

October 30, 2017

Primary Completion

May 31, 2018

Study Completion

May 31, 2018

Last Updated

October 14, 2019

Record last verified: 2019-10

Locations